[HTML][HTML] Intramolecular interaction kinetically regulates fibril formation by human and mouse α-synuclein
T Ohgita, H Kono, I Morita, H Oyama, T Shimanouchi… - Scientific reports, 2023 - nature.com
Regulation of α-synuclein (αS) fibril formation is a potent therapeutic strategy for αS-related
neurodegenerative disorders. αS, an intrinsically disordered 140-residue intraneural protein …
neurodegenerative disorders. αS, an intrinsically disordered 140-residue intraneural protein …
Intramolecular interaction kinetically regulates fibril formation by human and mouse α-synuclein.
T Ohgita, H Kono, I Morita, H Oyama… - Scientific …, 2023 - europepmc.org
Regulation of α-synuclein (αS) fibril formation is a potent therapeutic strategy for αS-related
neurodegenerative disorders. αS, an intrinsically disordered 140-residue intraneural protein …
neurodegenerative disorders. αS, an intrinsically disordered 140-residue intraneural protein …
Intramolecular interaction kinetically regulates fibril formation by human and mouse α-synuclein
T Ohgita, H Kono, I Morita, H Oyama… - Scientific …, 2023 - okayama.elsevierpure.com
Regulation of α-synuclein (αS) fibril formation is a potent therapeutic strategy for αS-related
neurodegenerative disorders. αS, an intrinsically disordered 140-residue intraneural protein …
neurodegenerative disorders. αS, an intrinsically disordered 140-residue intraneural protein …
[HTML][HTML] Intramolecular interaction kinetically regulates fibril formation by human and mouse α-synuclein
T Ohgita, H Kono, I Morita, H Oyama… - Scientific …, 2023 - ncbi.nlm.nih.gov
Regulation of α-synuclein (αS) fibril formation is a potent therapeutic strategy for αS-related
neurodegenerative disorders. αS, an intrinsically disordered 140-residue intraneural protein …
neurodegenerative disorders. αS, an intrinsically disordered 140-residue intraneural protein …
Intramolecular interaction kinetically regulates fibril formation by human and mouse α-synuclein.
T Ohgita, H Kono, I Morita, H Oyama… - Scientific …, 2023 - search.ebscohost.com
Regulation of α-synuclein (αS) fibril formation is a potent therapeutic strategy for αS-related
neurodegenerative disorders. αS, an intrinsically disordered 140-residue intraneural protein …
neurodegenerative disorders. αS, an intrinsically disordered 140-residue intraneural protein …
Intramolecular interaction kinetically regulates fibril formation by human and mouse α-synuclein
T Ohgita, H Kono, I Morita, H Oyama… - Scientific …, 2023 - pubmed.ncbi.nlm.nih.gov
Regulation of α-synuclein (αS) fibril formation is a potent therapeutic strategy for αS-related
neurodegenerative disorders. αS, an intrinsically disordered 140-residue intraneural protein …
neurodegenerative disorders. αS, an intrinsically disordered 140-residue intraneural protein …
Intramolecular interaction kinetically regulates fibril formation by human and mouse α-synuclein
T Ohgita, H Kono, I Morita, H Oyama… - Scientific …, 2023 - ui.adsabs.harvard.edu
Regulation of α-synuclein (αS) fibril formation is a potent therapeutic strategy for αS-related
neurodegenerative disorders. αS, an intrinsically disordered 140-residue intraneural protein …
neurodegenerative disorders. αS, an intrinsically disordered 140-residue intraneural protein …
Intramolecular interaction kinetically regulates fibril formation by human and mouse α-synuclein
T Ohgita, H Kono, I Morita, H Oyama, T Shimanouchi… - Scientific Reports, 2023 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Regulation of α-synuclein (αS) fibril formation
is a potent therapeutic strategy for αS-related neurodegenerative disorders. αS, an …
is a potent therapeutic strategy for αS-related neurodegenerative disorders. αS, an …
Intramolecular interaction kinetically regulates fibril formation by human and mouse α-synuclein.
T Ohgita, H Kono, I Morita, H Oyama… - Scientific …, 2023 - europepmc.org
Regulation of α-synuclein (αS) fibril formation is a potent therapeutic strategy for αS-related
neurodegenerative disorders. αS, an intrinsically disordered 140-residue intraneural protein …
neurodegenerative disorders. αS, an intrinsically disordered 140-residue intraneural protein …
Intramolecular interaction kinetically regulates fibril formation by human and mouse α-synuclein
T Ohgita, H Kono, I Morita, H Oyama… - Scientific …, 2023 - okayama.elsevierpure.com
抄録 Regulation of α-synuclein (αS) fibril formation is a potent therapeutic strategy for αS-
related neurodegenerative disorders. αS, an intrinsically disordered 140-residue intraneural …
related neurodegenerative disorders. αS, an intrinsically disordered 140-residue intraneural …